Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.

NCT01569113 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Emergency Contraception

Interventions

DRUG: Ulipristal Acetate (UPA) + ethinylestradiol/levonorgestrel (Microgynon)
DRUG: placebo + ethinylestradiol/levonorgestrel

Sponsor

HRA Pharma